To evaluate the effect of Qizhiweitong granules on biomarkers in patients with chronic non-atrophic gastritis based on metabolomics
- Conditions
- Chronic non-atrophic gastritis
- Registration Number
- ITMCTR2100004932
- Lead Sponsor
- The First Hospital of Hebei Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Aged older than 18 years;
2. Patients were diagnosed as chronic non-atrophic gastritis (treatment group) by doctors and gastroscopy and pathological examination, otherwise they were considered as healthy subjects (control group);
3. Have not taken any drugs or health care products in the 14 days before enrollment;
4. Signing the informed consent.
1. Menstrual, pregnant and lactating women;
2. Metabolism related diseases and other digestive diseases;
3. Subjects who reported other digestive diseases, such as peptic ulcer, panpancreatitis, hepatitis, and cirrhosis of the liver;
4. Severe heart, brain, liver, kidney or hematopoietic system dysfunction or other serious diseases;
5. Serious mental illness (such as schizophrenia, depression, anxiety, etc.);
6. Some factors that affect stomach function, such as diet and lifestyle;
7. Food or drug allergies;
8. Unable to return to the doctor on time, lost to follow-up or incomplete data;
9. Discontinuation of treatment due to adverse reactions.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endogenous substances in urine;Endogenous substances in plasma;Endogenous substances in saliva;
- Secondary Outcome Measures
Name Time Method